首页> 外文会议>2012 IEEE 6th International Conference on Systems Biology. >An integrative framework for identifying consistent microRNA expression signatures associated with clear cell renal cell carcinoma
【24h】

An integrative framework for identifying consistent microRNA expression signatures associated with clear cell renal cell carcinoma

机译:用于鉴定与透明细胞肾细胞癌相关的一致的microRNA表达特征的综合框架

获取原文
获取原文并翻译 | 示例

摘要

Clear cell renal cell carcinoma (ccRCC) is the most common and invasive renal-originated malignancy. Altered microRNA expression has been observed in many human cancers including ccRCC. Microarray is routinely used in labs worldwide for detecting cancer specific microRNA expression profiles, but no consistent conclusion could be drawn so far. The function of microRNAs in carcinogenesis of this tumor type is thereof largely unknown. In this study, we describe an integrative framework to improve the comparability of differentially expressed microRNAs (DE-miRNAs) from different experiments, and apply it to 4 publicly available microRNA expression datasets in ccRCC. The approach uses a novel statistic method for cancer outlier detection. The identified DE-miRNAs are then screened by POMA, an in-house developed predictor, for microRNAs with real regulatory activity in the disease. The proposed framework not only achieves high reproducibility across different datasets but also identifies a consistent set of 12 DE-miRNAs which could be putative biomarkers and therapeutic targets. The targets of DE-miRNAs in each dataset were then mapped to functional databases for enrichment analysis. Both novel and previously characterized microRNA-regulated molecular pathways are identified that are likely to contribute to the pathogenesis of ccRCC. Overlapping comparison suggests that independent ccRCC expression profiles are more consistent at pathway level than that at gene/microRNA level.
机译:透明细胞肾细胞癌(ccRCC)是最常见的浸润性肾源性恶性肿瘤。在包括ccRCC在内的许多人类癌症中都观察到了microRNA表达的改变。微阵列在全世界的实验室中常规用于检测癌症特异性microRNA表达谱,但到目前为止尚不能得出一致的结论。 microRNA在这种肿瘤类型的癌变过程中的功能尚不清楚。在这项研究中,我们描述了一个整合的框架,以提高不同实验中差异表达的microRNA(DE-miRNA)的可比性,并将其应用于ccRCC中的4个公开可用的microRNA表达数据集。该方法使用一种新颖的统计方法来检测癌症异常值。然后通过内部开发的预测因子POMA筛选已鉴定的DE-miRNA,以筛选在疾病中具有真正调控活性的microRNA。所提出的框架不仅在不同数据集上实现了高重现性,而且还确定了一致的12种DE-miRNA集合,这些DE-miRNA可能是假定的生物标志物和治疗靶标。然后将每个数据集中的DE-miRNA靶标映射到功能数据库中进行富集分析。新颖的和以前表征的microRNA调控的分子途径都被确定,可能有助于ccRCC的发病机理。重叠比较表明,独立的ccRCC表达谱在途径水平上比在基因/ microRNA水平上更一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号